149 related articles for article (PubMed ID: 15160871)
1. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
Arikawa J; Okabe S; Kaneko T
J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
[No Abstract] [Full Text] [Related]
2. Allergic contact dermatitis to topical preparations of bufexamac.
Pan Y; Nixon R
Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
[No Abstract] [Full Text] [Related]
4. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
Nakada T; Matsuzawa Y
Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
[No Abstract] [Full Text] [Related]
5. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
6. Allergic contact dermatitis from topical piketoprofen.
Rodríguez-Lozano J; Goday Buján JJ; Del Pozo J; Fonseca E
Contact Dermatitis; 2005 Feb; 52(2):110-1. PubMed ID: 15725293
[No Abstract] [Full Text] [Related]
7. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
[No Abstract] [Full Text] [Related]
8. Allergic contact dermatitis from bufexamac cream.
Corazza M; Roveggio C; Virgili A
Contact Dermatitis; 1993 Oct; 29(4):219. PubMed ID: 8281796
[No Abstract] [Full Text] [Related]
9. Allergic contact dermatitis due to aceclofenac.
Pitarch Bort G; de la Cuadra Oyanguren J; Torrijos Aguilar A; García-Melgares Linares ML
Contact Dermatitis; 2006 Dec; 55(6):365-6. PubMed ID: 17101014
[No Abstract] [Full Text] [Related]
10. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
[TBL] [Abstract][Full Text] [Related]
11. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Wong GN; Shen S; Nixon R
Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
[No Abstract] [Full Text] [Related]
12. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
13. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
Gniazdowska B; Ruëff F; Przybilla B
Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
[TBL] [Abstract][Full Text] [Related]
14. Bufexamac is a frequent contact sensitizer.
Kränke B; Derhaschnig J; Komericki P; Aberer W
Contact Dermatitis; 1996 Jan; 34(1):63-4. PubMed ID: 8789232
[No Abstract] [Full Text] [Related]
15. Contact urticaria due to ketoprofen.
Suzuki T; Kawada A; Hashimoto Y; Isogai R; Aragane Y; Tezuka T
Contact Dermatitis; 2003 May; 48(5):284-5. PubMed ID: 12868980
[No Abstract] [Full Text] [Related]
16. Contact dermatitis from peppermint and menthol in a local action transcutaneous patch.
Foti C; Conserva A; Antelmi A; Lospalluti L; Angelini G
Contact Dermatitis; 2003 Dec; 49(6):312-3. PubMed ID: 15025712
[No Abstract] [Full Text] [Related]
17. Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel.
Sánchez-Pérez J; Sánchez TS; García-Díez A
Am J Contact Dermat; 2001 Dec; 12(4):215-6. PubMed ID: 11753896
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
[TBL] [Abstract][Full Text] [Related]
19. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac.
Kurumaji Y
Dermatology; 1998; 197(2):183-6. PubMed ID: 9732173
[TBL] [Abstract][Full Text] [Related]
20. Oral piroxicam-induced dyshidrosiform dermatitis.
Piqué E; Pérez JA; Benjumeda A
Contact Dermatitis; 2004 Jun; 50(6):382-3. PubMed ID: 15274738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
